XLRN - Acceleron Pharma's (XLRN) CEO Habib Dable On Q3 2020 Results - Quick Version Earnings Call Transcript

Acceleron Pharma Inc. (XLRN) Q3 2020 Earnings Conference Call October 5, 2020 4:50 PM ET Company Participants Jamie Bernard – Associate Director-Investor Relations Habib Dable – Chief Executive Officer Kevin McLaughlin – Chief Financial Officer Sujay Kango – Chief Commercial Officer Jay Backstrom – Head-Research and Development Conference Call Participants Gabe Daoud – Cowen Carter Gould – Barclays Charles Song – SVB Leerink Chris Raymond – Piper Sandler Eric Joseph - J.P. Morgan Yigal Nochomovitz – Citigroup Bikramjot Singh – RBC Capital Markets Presentation Disclaimer: *NEW* We are providing this transcript version in a raw, machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure. Please enjoy this timely version in the interim. Operator [00:00:01] Good afternoon, ladies and gentlemen, and welcome to the Acceleron third quarter Twenty twenty earnings

For further details see:

Acceleron Pharma's (XLRN) CEO Habib Dable On Q3 2020 Results - Quick Version Earnings Call Transcript